Introduction And Hypothesis: Our study compared high levator myorrhaphy (HLM) and uterosacral ligament suspension (USLS) for vaginal apex fixation from both an anatomical and functional point of view, and assessed the impact of surgery on quality of life (QoL) and sexuality.

Methods: Two hundred twenty-nine patients with symptomatic stage >or=2 apical prolapse were randomized to USLS or HLM. Those patients who also needed cystocele repair additionally underwent an anterior prosthetic reinforcement. We defined as cure no prolapse of stage 2 or greater in any compartments according to the POP-Q system.

Results: Correction of apical prolapse was observed in 96.6% of the HLM group and 98.3% of the USLS group. However, a persistent anterior wall prolapse occurred in 29.2% of the HLM group and in 35.4% of the USLS group. Both groups reported improvement in storage, voiding, and prolapse-related symptoms. Urodynamics of patients in the HLM group showed post-operative reduction in detrusor pressure at maximum flow and an increase in maximum flow. Both groups saw similar improvement in QoL. We did not encounter any serious side effects, except for nine cases of intraoperative ureteral occlusion following USLS.

Conclusion: This study demonstrates similar efficacy of HLM and USLS for vaginal apex suspension; however, USLS has a higher incidence of complications involving the upper urinary tract.

Download full-text PDF

Source
http://dx.doi.org/10.1007/s00192-009-1064-xDOI Listing

Publication Analysis

Top Keywords

hlm group
12
high levator
8
uterosacral ligament
8
ligament suspension
8
suspension usls
8
usls vaginal
8
vaginal apex
8
apical prolapse
8
usls group
8
maximum flow
8

Similar Publications

Investigating 3-CMC metabolism: Insights from liver microsomes and postmortem biological matrix.

Forensic Sci Int

January 2025

Laboratoire de Pharmacologie - Toxicologie, CHU de Saint-Etienne, Saint-Etienne, France; INSERM, UMR 1059, Dysfonction Vasculaire et de l'Hémostase, Université de Lyon, Saint-Etienne, France. Electronic address:

3-Chloromethcathinone (3-CMC) is a synthetic cathinone that has been identified as a new psychoactive substance (NPS) by the European Monitoring Centre for Drugs and Drug Addiction. Despite its increasing prevalence in the recreational drug market since 2014, scientific literature on 3-CMC remains limited. This study employed a multi-step approach to investigate 3-CMC metabolism.

View Article and Find Full Text PDF
Article Synopsis
  • Medical students are under a lot of stress and mental health issues, and this study looked into how self-determination theory (SDT) could boost their motivation and decrease stress during learning.
  • The study involved a week-long psychiatry course where one group of students experienced a new teaching style focused on autonomy and positive reinforcement, compared to a traditional approach.
  • Results showed that the innovative method increased intrinsic motivation and perceived autonomy while reducing stress, though it also led to lower exam scores due to the lack of critical feedback.
View Article and Find Full Text PDF

Ponatinib is approved for use in patients with chronic myeloid leukemia (CML) who are resistant to or intolerant to prior tyrosine kinase inhibitor (TKI) therapy. Given that ponatinib can induce significant cardiotoxicity when taken, and that most Chinese medicines have cardioprotective effects, it is possible to administer them in combination in clinic to alleviate adverse effects. The quantitative determination of ponatinib and its metabolite N-desmethyl ponatinib was optimized and fully verified by ultra performance liquid chromatography tandem mass spectrometry (UPLC-MS/MS).

View Article and Find Full Text PDF

Mobility Loss in Hospitalized Adults Predicts Poor Clinical Outcomes.

J Nurs Care Qual

October 2024

Author Affiliations: Department of Medicine, Division of Geriatrics, University of California, San Francisco, California (Dr. Rogers); University of Utah School of Medicine, Salt Lake City, Utah (Mulvey); Department of Medicine, Division of Geriatrics, University of California, San Francisco, California (Turingan); Department of Rehabilitation Services, UCSF Health, San Francisco, California (Coco); Department of Medicine, Division of Hospital Medicine, UCSF, San Francisco, California (Hubbard); Department of Nursing, UCSF, San Francisco, California (Binford); and Department of Medicine, Division of Hospital Medicine, UCSF, San Francisco, California (Harrison).

Article Synopsis
  • The Johns Hopkins Activity and Mobility Program aims to track and enhance patient mobility.
  • A study was conducted to see how loss of mobility impacts various health outcomes, categorizing patients based on their mobility changes.
  • Results showed that patients who experienced mobility loss faced higher risks of falls, in-hospital mortality, delirium, longer hospital stays, and were more likely to be discharged to a care facility, but mobility loss did not affect 30-day readmissions.
View Article and Find Full Text PDF

Lack of patient diversity in clinical trial enrollment remains an obstacle to achieving equitable healthcare outcomes. Under-representation has resulted in non-generalizable clinical knowledge, inequitable access to treatment, and health disparities among minority and disadvantaged groups. A multidisciplinary panel was convened to consider the challenges of diverse patient accrual and provide actionable solutions to improve representation in clinical trials.

View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!